Kidney Transplant Single Cadaver donor | Kidney Transplant Single Living Donor
Item
patients undergoing a single renal transplant from deceased or living donor
boolean
C0022671 (UMLS CUI [1,1])
C0205171 (UMLS CUI [1,2])
C0524354 (UMLS CUI [1,3])
C0022671 (UMLS CUI [2,1])
C0205171 (UMLS CUI [2,2])
C0348050 (UMLS CUI [2,3])
Adult | Age
Item
adults 18 years and older
boolean
C0001675 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
Kidney Transplant First | Kidney Transplant second
Item
first or second renal transplant
boolean
C0022671 (UMLS CUI [1,1])
C0205435 (UMLS CUI [1,2])
C0022671 (UMLS CUI [2,1])
C0205436 (UMLS CUI [2,2])
Study Protocol Comprehension | Informed Consent | Protocol Compliance
Item
capable of understanding the purposes of the study, has given written informed consent, and agrees to comply with the study requirements
boolean
C2348563 (UMLS CUI [1,1])
C0162340 (UMLS CUI [1,2])
C0021430 (UMLS CUI [2])
C0525058 (UMLS CUI [3])
Childbearing Potential Serum pregnancy test negative
Item
women of child bearing age should have a negative serum pregnancy test
boolean
C3831118 (UMLS CUI [1,1])
C0430061 (UMLS CUI [1,2])
Kidney Transplant Quantity
Item
greater than 2 renal transplants
boolean
C0022671 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
Age
Item
age < 18 years
boolean
C0001779 (UMLS CUI [1])
Therapeutic immunosuppression | Kidney Transplant First | Kidney Transplant second
Item
patients receiving immunosuppressive therapy within the preceding 28 days for first transplant and 3 months for the second transplant
boolean
C0021079 (UMLS CUI [1])
C0022671 (UMLS CUI [2,1])
C0205435 (UMLS CUI [2,2])
C0022671 (UMLS CUI [3,1])
C0205436 (UMLS CUI [3,2])
Cold Ischemia Time
Item
cold ischemia time > 30 hours
boolean
C1563922 (UMLS CUI [1])
Malignant Neoplasms | Skin carcinoma Localized Treated Successful
Item
history of malignancy in the last 5 years except successfully treated localized non-melanoma skin cancer
boolean
C0006826 (UMLS CUI [1])
C0699893 (UMLS CUI [2,1])
C0392752 (UMLS CUI [2,2])
C1522326 (UMLS CUI [2,3])
C1272703 (UMLS CUI [2,4])
HIV Seropositivity | Hepatitis B Virus Seropositive | Hepatitis C virus Seropositive
Item
hiv, hepatitis b virus (hbv), or hepatitis c virus (hcv) positive serology
boolean
C0019699 (UMLS CUI [1])
C0019169 (UMLS CUI [2,1])
C0521143 (UMLS CUI [2,2])
C0220847 (UMLS CUI [3,1])
C0521143 (UMLS CUI [3,2])
Transplant Loss
Item
loss of previous transplant in < 1 year
boolean
C0332835 (UMLS CUI [1,1])
C1517945 (UMLS CUI [1,2])
Non-compliance
Item
history of non-compliance
boolean
C0457432 (UMLS CUI [1])
Substance Use Disorders | Mental disorders | Condition Protocol Compliance Limited
Item
any form of substance abuse, psychiatric disorder or condition which, in the opinion of the investigator, may impair communication with the investigator or compliance with study procedures
boolean
C0038586 (UMLS CUI [1])
C0004936 (UMLS CUI [2])
C0348080 (UMLS CUI [3,1])
C0525058 (UMLS CUI [3,2])
C0439801 (UMLS CUI [3,3])
Organ Transplant multiple
Item
multiple organ transplant
boolean
C0029216 (UMLS CUI [1,1])
C0439064 (UMLS CUI [1,2])
steroid use chronic | Inhaled steroids use Asthma
Item
history of chronic steroid use except for inhaled steroids for asthma
boolean
C0281991 (UMLS CUI [1,1])
C0205191 (UMLS CUI [1,2])
C0586793 (UMLS CUI [2,1])
C0004096 (UMLS CUI [2,2])
Pregnancy | Breast Feeding
Item
pregnant or lactating females
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Childbearing Potential Contraceptive methods Inadequate
Item
women of childbearing potential not willing to use a reliable form of contraception.
boolean
C3831118 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
C0205412 (UMLS CUI [1,3])
Medical condition Severe | Study Subject Participation Status Exclusion
Item
patients with severe medical condition(s) that, in the view of the investigator, prohibits participation in the study
boolean
C3843040 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C2348568 (UMLS CUI [2,1])
C2828389 (UMLS CUI [2,2])
Hypersensitivity Investigational New Drugs | Hypersensitivity Class of Trial Agent
Item
known sensitivity to study drugs or class of study drugs
boolean
C0020517 (UMLS CUI [1,1])
C0013230 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C2983595 (UMLS CUI [2,2])
Investigational New Drugs
Item
use of any investigational agent in the last 30 days
boolean
C0013230 (UMLS CUI [1])